Valuation: Burning Rock Biotech Limited

Market Cap 1.25B 186M 164M 155M 140M 263M 17.85B 265M 1.85B 715M 9.11B 698M 683M 29.27B P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 811M 121M 106M 100M 91.08M 171M 11.59B 172M 1.2B 464M 5.91B 453M 444M 19.01B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
96.23%
Yield 2024 *
-
Yield 2025 -
1 day-0.45%
1 week+19.69%
Current month+86.56%
1 month+73.01%
3 months+113.18%
6 months+7.76%
Current year-12.51%
1 week 14.35
Extreme 14.35
19.6
1 month 9.15
Extreme 9.15
19.6
Current year 6.79
Extreme 6.79
41.72
1 year 6.79
Extreme 6.79
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
183.7
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 2013-12-31
Chief Executive Officer 48 2013-12-31
Director of Finance/CFO - 2024-09-26
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 2014-05-31
Director/Board Member 63 2016-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
3/31/26 Buy

Chief Executive Officer

314,870 0.3584%
3/18/26
Northern Light Venture Capital Development Ltd.
OtherCompany 11,880,245 13.5213%
3/17/26 Other

Director

22,718 0.0259%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%+19.69%+97.41%+89.98% 186M
+0.11%+6.06%+154.21%+836.94% 59.35B
-0.12%-1.10%+8.97%+53.26% 25.11B
-1.42%-2.04%-11.73%-37.11% 6.59B
-1.00%-3.46%-4.45%+153.19% 5.65B
+0.43%+2.13%+24.51%+54.53% 3.38B
-0.80%-6.56%-25.53%+2,230.91% 2.56B
-1.27%+1.22%+146.07%+55.45% 2.48B
+16.17%-1.94%+34.32%+43.10% 2.23B
-1.29%+0.87%-0.51%-53.48% 1.97B
Average +1.01%+0.48%+42.33%+342.68% 10.95B
Weighted average by Cap. +0.06%+4.44%+89.02%+526.68%

Financials

2024 2025
Net sales 516M 76.83M 67.57M 63.9M 57.96M 109M 7.37B 109M 765M 295M 3.76B 288M 282M 12.09B 540M 80.37M 70.68M 66.84M 60.62M 114M 7.71B 115M 800M 309M 3.94B 302M 295M 12.65B
Net income -347M -51.63M -45.41M -42.94M -38.95M -73.14M -4.96B -73.56M -514M -199M -2.53B -194M -190M -8.13B -55.35M -8.24M -7.25M -6.86M -6.22M -11.68M -791M -11.75M -82.09M -31.7M -404M -30.95M -30.28M -1.3B
Net Debt -474M -70.55M -62.05M -58.67M -53.22M -99.95M -6.77B -101M -703M -271M -3.46B -265M -259M -11.1B -438M -65.19M -57.33M -54.22M -49.17M -92.35M -6.26B -92.89M -649M -251M -3.19B -245M -239M -10.26B
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
-
Date Price Change Volume
26-09-28 $17.63 -5.22% 86,327
26-09-25 $18.60 +3.33% 39,520
26-09-24 $18.00 +19.40% 135,977
26-09-23 $15.08 -8.36% 24,099
26-09-22 $16.45 +11.68% 20,244